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UNITED STATES FOOD LAW UPDATE:
CONSUMER PROTECTIONS AND ACCESS TO
INFORMATION: RBST, BPA, THE ADA AND
COLOR ADDITIVES
A. Bryan Endres*
Five significant legal developments in the first half of 2008 war-
rant examination in this version of the Food Law Update. Compre-
hensive discussions of recombinant bovine somatotropin (rBST)-
related dairy product labeling and regulatory actions regarding
Bisphenol A (BPA) use in food and food contact materials comprise
the bulk of this article's analysis. Briefer discussions concerning
consumer class action litigation for false advertising claims, an
Americans with Disabilities Act case from the Second Circuit Court
of Appeals and New York City Board of Health regulations requir-
ing certain chain restaurants to post caloric content information on
menus comprise the balance of this edition of the update.
As in the previous updates, necessity dictates that not every
change is included; rather, this update is limited to significant
changes within the broader context of food production and retail.
This series of updates provides a starting point for scholars, practi-
tioners, food scientists, and policymakers determined to understand
the shaping of food law in modern society. Tracing the develop-
ment of food law through these updates also builds an important
historical context for the overall development of the discipline.
* Assistant Professor of Agricultural Law, University of Illinois. This research
is supported by the Cooperative State Research Education & Extension Service,
USDA, Project No. ILLU470-309. Any opinions, findings, and conclusions or rec-
ommendations expressed in this publication are those of the author and do not
necessarily reflect the view of the funding agency. The author expresses his appre-
ciation for the excellent research assistance of two law students at the University of
Illinois: Daniel S. Lohse (J.D. expected 2009) and Stephanie B. Johnson (J.D. ex-
pected 2010).
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I. CONSUMERS, TECHNOLOGY, MILK AND RBST LABELS:
A CASE STUDY OF ORTHOGONAL RELATIONSHIPS WITH
THE FIRST AMENDMENT
Although approved by the Food and Drug Administration
("FDA") sixteen years ago,' recombinant bovine somatotropin
(rBST), also known as recombinant bovine growth hormone
(rBGH),2 continues to engender significant controversy. Marketed
under the trade name Posilac,3 some dairy farmers use rBST to
stimulate milk production. While the FDA asserts that milk from
animals injected with rBST shows no significant differences when
compared to that of untreated animals,4 some argue that the studies
relied upon by the FDA in approving use of the hormone were not
sufficient5 and that, regardless of the hormone's safety, consumers
1. Animal Drugs, Feeds, and Related Products; Sterile Sometribove Zinc Sus-
pension, 58 Fed Reg. 59946-02 (Nov. 12, 1993).
2. Bovine Somatotropin (BST), INST. FOOD SCI. AND TECHNOLOGY, Jan. 2004,
available at http://ifst.org/uploadedfiles/cms/store/ATACHMENT/BST.pdf.
The term "rBST" and "rBGH" both refer to Monsanto's synthetic hormone. rBST
is the scientific description of the hormone although rBGH is sometimes used to
refer to the product.
3. The Monsanto Company (Monsanto) markets rBST under the trade name
Posilac and is the sole producer of the synthetic hormone. MONSANTO Co., Annual
Report (Form 10-K), at 5 (Nov. 25, 2003). In August, 2008, Monsanto sold the
worldwide rights to Posilac to the Indiana-based Elanco for $300 million. Press
Release, Elanco, Elanco Announces Acquisition of Posilac Dairy Business: Deal
Provides Strategic Fit with Lilly's Animal Health Division (Aug. 20, 2008), available
at http://www.elanco.com/images/PosilacAcquisitionPressRelease_08-20-08.pdf.
The sale should close by the end of the fourth quarter of 2008. Monsanto's pro-
duction of the hormone marketed as Posilac also appears to be quite profitable.
Although the company does not release specific sales figures, Posilac sales are esti-
mated at around $250 million-comprising approximately 3.5% of the company's
total sales. Andrew Pollack, Which Cows do you Trust, N.Y. TIMES, Oct. 7, 2006, at
C1.
4. FDA, Interim Guidance on the Voluntary Labeling of Milk and Milk Prod-
ucts from Cows that have not Been Treated with Recombinant Bovine Somatotro-
pin, 59 Fed. Reg. 6279, 6279-80 (Feb. 10, 1994) [hereinafter FDA Interim rBST
Guidance]. See also Bovine Somatotropin Technology Assessment Conference Statement,
NATIONAL INSTITUTE OF HEALTH, OFFICE OF MEDICAL APPLCATIONS OF RESEARCH,
Technology Conference Statement, Dec. 5-7, 1990, available at http://www.
monsantodairy.com/about/human-safety/print/pnihtassessment.html (describing
safety aspects of rBST); John Vicini, et al., Survey of Retail Milk Composition as Af-
fected by Label Claims Regarding Farm-Management Practices, 108 J. OF AM. DIETETIC
ASs'N 1198 (2008) (finding milk labeled rBST-free has similar, although not excact,
concentrations of certain chemicals as conventional and organic milk).
5. See Christina Cusimano, RBST, It Does a Body Good?: RBST Labeling and the
Federal Denial of Consumers' Right to Know, 48 SANTA CLARA L. REV. 1095, 1105-07
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have a right to know which products are derived from the milk of
rBST-injected cows.' Because the FDA has provided only non-
binding guidance regarding voluntary labeling of the presence or
absence of rBST use in milk production,' significant debate contin-
ues regarding the permissibility and methods of labeling dairy
products derived from rBST-injected cows.8
Some farmers electing not to use rBST have attempted to mar-
ket their products with labels claiming to be free of the hormone.'
Monsanto, the manufacturer of rBST, has fought vigorously such
labeling. Relying on the FDA's 1994 interim labeling guidance, it
claims that such labels are misleading and falsely imply that rBST-
free production methods result in safer products than those pro-
duced without use of the engineered hormone.'" Legislatures,
courts, consumers, and corporations have all spoken out on the is-
sue, leading to a controversial standoff with few clear answers. The
following discussion reviews the government's approval of rBST,
legal challenges to mandatory labeling rules, consumer and food
(2008) (arguing that the long-term effects of rBST have not been studied and that
former Monsanto employees were integral in FDA's approval of the hormone).
6. Cusimano, supra note 5, at 1112.
7. FDA Interim rBST Guidance, supra note 4, at 6280.
8. As this article went to print, the DrakeJournal of Agricultural Law published
an excellent article by Professor McCabe detailing the recent controversy surround-
ing rBST labeling. For a more detailed discussion of this topic, see Margaret Sova
McCabe, Got Controversy? Milk Does, 13 DrakeJ. Agri. L. 475 (Fall 2008).
9. Cusimano, supra note 5 at 1109-1113.
10. Id. at 1013-14. While some disagree about the long-term research regarding
the effects of rBST, one recent study suggests that diary products from rBST-
treated animals are compositionally virtually indistinguishable from more tradi-
tional products. The study, published by the Journal of the American Dietetic As-
sociation, compared rBST-treated products with rBST-free and organic milk for
quality, nutrients, and hormones. None of the milk samples tested returned signifi-
cant levels of detectable antibiotics and there were no reported differences between
the three types in milk fat, lactose, or solids. Additionally, the study found no dif-
ferences in bST hormone concentrations, even in those products derived from
rBST-treated cows. The study concluded by reporting that few compositional dif-
ferences were detected between conventional, organic, and rBST-free milk. The
study focused only on the composition of milk and did not substantially investigate
the health of the animals injected with the hormone. The authors did note that,
despite the lack of significant compositional differentiation, the price of the three
types of milk varied quite substantially. Organic and rBST-free labeled milk sold
for approximately $1.00-$4.00 more per gallon than conventional milk derived
from cows injected with rBST. John Vicini, et al., Survey of Retail Milk Composition as
Affected by Label Claims Regarding Farm-Management Practices, 108 J. Am. Dietetic
Assoc. 1198, 1198 (2008).
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industry trends, and recent state-level attempts to prohibit or restrict
voluntary rBST labeling.
A. FDA Appoval of rBST
Bovine somatotropin (BST) is a protein hormone produced by
the pituitary gland that naturally exists in dairy cows and contributes
to lactation." rBST is a synthetic version of this naturally occurring
hormone that is injected into cows to increase their milk production
and growth.'" Shortly after FDA's approval of rBST, some dairy
producers began marketing campaigns promoting their products as
"rBST-free."'3
Amid objection to the rBST-free labels from both Monsanto
and farmers who chose to use the synthetic hormone, the FDA is-
sued interim labeling guidance.'4 After reiterating that the hormone
is safe and effective for dairy cows and that milk derived from in-
jected animals is safe for human consumption,'5 the FDA stated that
it does not have the authority to mandate labels on milk from cows
treated with rBST." Although the Federal Food, Drug, and Cos-
metic Act grants the FDA jurisdiction to regulate product labeling,
the agency's interim guidelines noted that it has no authority to re-
quire disclosure when it determines that there is no significant im-
pact from use of the hormone.'7 Additionally, the FDA stated that
milk labeling should primarily be a state concern, with the FDA's
findings used as guidance in developing state/local rules.'8 The
agency did specify that producers may voluntarily label their prod-
ucts concerning the absence or presence of rBST treatment so long
as all statements are truthful and not misleading.'9 While the FDA
made clear that it would not mandate rBST labeling, it left open for
debate what falls under "truthful and not misleading.""0
11. Cusimano, supra note 5, at 1098.
12. Id. Posilac is used to boost milk production by as much as forty percent per
day. Jennifer R. Thornley, Got "Hormone-Free" Milk?: Your State May Have Enough
Interest to Let You Know, 76 IND. L.J. 785, 785 (2001).
13. Id. at 786.
14. FDA Interim rBST Guidance, supra note 4, at 6279-80.
15. Id.
16. Id. at 6280.
17. Id.
18. Id.
19. FDA Interim rBST Guidance, supra note 4, at 6280.
20. The "truthful and misleading" requirement is nothing new, as the FFDCA
has always prohibited false or misleading labels. See 21 U.S.C. § 343(a) (2000).
[VOL. 4:263
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"False" labels generally are easier to identify than "misleading"
labels. For example, it would be false for any milk producer to
claim that its product is "BST-free" or "hormone-free," as BST is a
naturally occurring hormone present in all milk-producing cows.'
Indeed, FDA has issued warning letters to various firms attempting
to market dairy products as "Hormone Free."22 Claiming that milk is
"rBST-free," however, may be true, but potentially misleading.
There is "no way to differentiate analytically between naturally oc-
curring bST and [rBST]... in milk" products.23 Moreover, the FDA is
unaware of any measurable compositional difference from cows re-
ceiving supplemental rBST and cows that do not.24 Accordingly, in
its interim guidelines, the FDA noted that claiming a product is free
of the hormone rBST may imply a compositional difference be-
tween the conventional milk product and milk from animals treated
with rBST-a claim the FDA regards as false.25 To avoid these poten-
tially misleading statements, the agency specified language that may
avoid confusion, citing the following as an example of a truthful and
not misleading label: This milk is "'from cows not treated with rBST'
accompanied with the qualifying statement that 'No significant dif-
ference has been shown between milk derived from rBST-treated
and non-rBST-treated cows."' While the FDA's guidance is helpful,
it remains non-binding and opens the door for states to struggle
with their own rBST-related labeling rules.
21. FDA Interim rBST Guidance, supra note 4, at 6280.
22. Modified Warning Letter from Joseph R. Baca, Director, Office of Compli-
ance, Center for Food Safety and Applied Nutrition, to George Economy, Pride of
Main Street Dairy LLC (Sept. 24, 2003) (stating that the "No Hormones" label on
various dairy products is false), available at http://www.fda.gov/foi/
warningietters/archive/g4305d.htm; Warning Letter from Joseph R. Baca, Direc-
tor, Office of Compliance, Center for Food Safety and Applied Nutrition, to Rich-
ard Osofsky, Ronnybrook Farm Dairy (Sept. 9, 2003) (stating that the "hormone
free" label on various dairy products is false), available at http://www.fda.gov/
foi/warningletters/archive/g4290d.htm.
23. FDA Interim rBST Guidance, supra note 4, at 6280.
24. Id.
25. See id. (noting that "[t]here is currently no way to differentiate analytically
-between naturally occurring bST and recombinant bST in milk, nor are there any
measurable compositional differences between milk from cows that receive sup-
plemental bST and milk from cows that do not.").
26. Id.
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B. Legal Status of Mandatory Labeling
Despite the FDA's conclusion that rBST is safe for human con-
sumption, some jurisdictions have attempted to mandate labeling of
rBST use either out of concern about the safety of Posilac or under
the rationale of promoting informed consumer choice.27 Indeed,
some jurisdictions (European Union, Canada, Australia and Japan)
have either prohibited the use of rBST or subjected products to
mandatory labeling.28 In 1994, Vermont enacted a statute mandat-
ing the labeling of dairy products derived from rBST injected cows.21
In response, the International Dairy Foods Association (IDFA),
among other concerned parties, sought to enjoin enforcement
claiming the statute violated dairy producers' First Amendment
right not to speak, as well as the Commerce Clause.
The district court denied IDFA's request for a preliminary in-
junction." On appeal, the Second Circuit reversed.2  The Court
held that the dairy producers and retailers had a First Amendment
right not to speak unless the state could establish a substantial inter-
est for labeling rBST derived products:
Vermont argued that its statute supported a "strong consumer
interest and the public's 'right to know.' ' '3 4 The court, however, held
that a "substantial state interest" cannot be established based merely
on consumer curiosity.3  Pointing again to the FDA's scientific re-
search and the inability of scientists to distinguish between the two
27. See Cusimano, supra note 5, at 1115-17 (discussing states' interest sufficient
to compel speech). George Raine, Got rBST in your Milk? Dairy Co-Op Bows to Pres-
sure to Stop Use of Hormone, SAN FRANcIsco CHRONICLE, Mar. 25, 2007.
28. European Union Council Decision 1999/879 (L 331/71) (EC) (banning
rBST); Recombinant Bovine Somatotropin (rBST), HEALTH CANADA, available at
http://www.hc-sc.gc.ca/dhp-mps/vet/issues-enjeux/rbst-stbr/index-eng.php (not-
ing that Canada's regulatory agency governing national public health has not ap-
proved rBST for sale in Canada); Thornley, supra note 12, at 53 (2001) (noting that
Australia banned rBST use); Cusimano, supra note 5, at 1104 (noting that New
Zealand, Europe, and Japan have banned rBST); see Mark Scolforo, Pennsylvania
Bars Hormone-Free Milk Labels, Roiling Industry, SAN DIEGO UNION-TRIBUNE, Nov. 13,
2007 (same).
29. VT. STAT. ANN. tit. 6, § 2754 (terminated by 1993, Adj. Sess., No. 127, § 4, as
amended by 1997, No. 61 § 272i, eff. Mar. 30, 1998).
30. Int'l Dairy Foods Assoc. v. Amestoy, 92 F.3d 67, 69 (2d Cir. 1996).
31. Int'l Dairy Foods Assoc. v. Amestoy, 898 F. Supp. 246, 254 (D. Vt. 1995), rev'd,
92 F.3d 67 (2d Cir. 1996).
32. Amestoy, 92 F.3d at 69.
33. Id. at 71.
34. Id. at 73.
35. Id.
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products, the Court ruled that consumer curiosity was insufficient
justification to infringe upon the First Amendment rights of dairy
producers.36
The Amestoy opinion included a vigorous dissent asserting that
the state interest was not limited to consumer curiosity, but also
substantive concerns regarding rBST's impact on the heath of hu-
mans and cows, the financial sustainability of small farms, and gen-
eral concerns regarding the manipulation of nature using biotech-
nology. 7 The proper question, in the dissent's view, is whether the
Constitution prohibits government from mandating disclosure of
truthful, relevant information to promote informed consumer
choice.38
Although the Second Circuit opinion certainly leaves open the
possibility that mandatory labeling could pass constitutional muster
if the state advanced a more substantive interest, 9 a generalized in-
terest in satisfying consumer curiosity appears to be a losing argu-
ment for states attempting to mandate labeling of otherwise scien-
tifically indistinguishable products. Rather, the court relegated
process-based labeling decisions to market forces. "[T]hose con-
sumers interested in such information should exercise the power of
their purses by buying products from manufacturers who voluntarily
reveal [the absence of rBST use]."'0
C. Consumer Demand, Pricing and Corporate Responses
Consumer demand, regardless of labeling mandates, ultimately
drives the business decisions of individual dairy producers. Assum-
ing rBST use improves dairy cows' productivity and has a positive
financial impact on farmers' on a microeconomic scale, the increase
in production does have a significant opportunity cost. Milk identi-
fied as being from rBST-free cows receives a substantial price pre-
mium in the dairy market. One price sampling study found a one to
four dollar price premium for "rBST-free" or "organic" milk.4'
Moreover, some farmers have found that marketing their products
as rBST-free has led to a boom in their sales. 2 A Natural Marketing
36. Id.




41. See Vicini, supra note 10, at 1202.
42. See Hormone-Free Milk Sales Stir Heated Debate, Los ANGELES TiEs, Jan. 19,
2007 at C-6.
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Institute survey indicated that fifty-three percent of shoppers desired
dairy free of antibiotics and hormones.4 3 Additionally, the Con-
sumer Reports National Research Center found that seventy-six per-
cent of consumers were at least somewhat concerned about the use
of artificial hormones in milk-producing animals and that eighty-
eight percent of grocery shoppers believed that milk derived from
synthetic hormone-injected cows should be labeled."
As suggested by the court, 5 rather than waiting for federal or
state rBST labeling rules, many companies responded to this in-
creased consumer demand for products produced without rBST
technology. In March 2008, Wal-Mart Stores, Inc. announced that it
will source the discount chain's Great Value brand milk from cows
that have not been injected with rBST.6 Additionally, the retailer
announced that Sam's Club will only offer milk purchased from
suppliers that do not treat their animals with the synthetic hor-
mone. Wal-Mart cited consumer demand and expectations as the
motivation for this policy change.
Similarly, the Kroger Company announced in 2007 that all milk
processed and sold by the grocery store and its various subsidiaries49
in the western half of the United States would be sourced entirely
from suppliers pledging to keep their cows rBST-freeY.5  The chain
further planned to extend this policy to stores in the Midwest and
Southeast in February 2008.5' In its press release, Kroger acknowl-
edged that the FDA has approved the use of rBST and has found no
difference between conventional and rBST milk, but justified the
43. Raine, supra note 27.
44. International Daity Foods Association Files Lawsuit to Stop Ohio's Unfair Labeling
Law, BusINEss WIRE, Jun. 30, 2008, available at http://www.businesswire.com/por-
tal/site/google/?ndmViewId=news view&newsld=20080630006071&newsLang=en.
45. Amestoy, 92 F.3d at 74.
46. Press Release, Wal-Mart Stores, Inc.,Wal-Mart Offers Private Label Milk Pro-




49. Press Release, Kroger Co., Kroger to Complete Transition to Certified rBST-
Free Milk by Early 2008 (Aug. 1, 2007), available at http://www.thekrogerco.com/
corpnews/corpnewsinfopressreleases_08012007.htm; this includes milk processed
and sold in City Market, Dillons, Fry's, Food 4 Less, Fred Meyer, King Soopers,
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company's decision on the growing consumer interest in the issue. 2
Wal-Mart and Kroger are not alone in the move away from milk de-
rived from cows treated with rBST. Appendix A lists corporate
policies regarding rBST use and labeling for several major food
processors and retailers.
As marketing claims become more prevalent, rBST-free certifi-
cation and other generalized "hormone-free" claims continue to
command a price premium. Because consumers seem to be willing
to pay more for dairy products derived from animals not treated
with rBST,0 more corporations likely will follow the trend. 4 In light
of the FDA's apparent satisfaction with its voluntary interim guid-
ance and private grocery/food service firms implementing a variety
of restrictive rBST production and labeling policies, proponents of
rBST have turned to the courts and litigation pressure to rectify the
proliferation of allegedly misleading rBST labels.
Specifically, Monsanto has made clear that it will take legal ac-
tion against those who make "rBST-free" related claims on their la-
bels without including the FDA's recommended disclaimer. For
example, in 2003, the company brought suit against Oakhurst Dairy
for a label it claimed was deceptive and misleading. Monsanto ob-
jected to Oakhurst's product labels which read: "Our Farmers'
Pledge: No Artificial Growth Hormones. '5 7 When Oakhurst refused
to change its label, Monsanto sought to enjoin the dairy's use of the
label. 8
Although Oakhurst initially claimed that it would not capitulate
to Monsanto's demands, 9 by the end of 2003, Oakhurst had sof-
52. Id. Kroger also pointed out that it has encouraged it suppliers to provide
rBST-free products for over a decade and was interested in and taking advantage of
the growing trend of rBST-free certification.
53. See C. Ford Runge & Lee Ann Jackson, Negative Labeling of Genetically Modi-
fied Organisms (GMOS): The Experience of rBST, 3 AGBIoFoRUM 310, 310 (2000)
available at www.agbioforum.missouri.edu.
54. See Terri Coles, Posilac-Free Lattes, REUTERS, Sept. 4, 2007, available at
http://features.us.reuters.com/wellbeing/news/9F4F0608-5B IF- 1DC-B082-
6BC8461Bp.html (describing plans of Starbucks to switch to rBST-free products
following strong consumer advocacy).





59. Susan Q. Stranahan, Monsanto vs. the Milkman, MOTHERJONES,Jan/Feb 2004,
at 20.
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tened its position and entered into settlement negotiations." The
parties reached an agreemente whereby Oakhurst is free to advertise
the absence of rBST treatment, but will include the FDA's recom-
mended disclosure statement regarding the lack of difference be-
tween products derived from rBST treated and untreated animals."
Monsanto's approach to eliminating what it considers mislead-
ing rBST-free labeling also includes alerting both the FDA and the
Federal Trade Commission (FTC) of labels that it considers "false
and deceptive advertising.613 Although Monsanto's primary com-
plaint is use of the term "rBST-free" without the FDA recommended
disclaimer, some complained of labels purport that milk produced
without the use of rBST is safer or healthier than products derived
from rBST-treated cows.' In response to Monsanto's complaint, the
FTC concluded that although an advertising statement that milk
from cows not treated with rBST might be accompanied by the
FDA's recommended disclaimer, the FDA's guidance "does not re-
quire this accompanying statement" and that a truthful and "proper
context could also be achieved by conveying a firm's reasons (other
than safety or quality) for choosing not to use milk from cows
treated with rBST. '6 5 In light of this preliminary determination,
FTC staff subsequently reviewed advertising claims of the companies
referenced in the Monsanto complaint and "did not find any exam-
ples of national or significant regional advertising campaigns that
made express or implied claims linking rBST to human health or
safety.""6 Accordingly, the FTC declined to undertake a formal in-
60. Sharon Kiley Mack, Oakhurst Reaches Settlement on Label: Dairy, Chemical Com-
pany Avoid Trial, BANGOR DAILY NEWS, Dec. 25, 2003, at Al.
61. Id.
62. Id.
63. Letter from Brian Robert Lowry, Asst. Gen. Counsel, Office of Policy, Stew-
ardship, Regulation, and Government, to Sheldon T. Bradshaw, Chief Counsel,
Food and Drug Admin. (Feb. 22, 2007) [hereinafter Letter to FTC], available at
http://www.ftc.gov/os/comments/monsanto/O70227letterMonsantorBST.pdf; See
also Monsanto Urges FDA to Stop "Misleading" rBST-Free Labeling, NON-GMO REPORT,
May 2007, available at http://www.non-gmoreport.com/articles/may07/
misleadingrBST-free-labeling.php.
64. Letter to FTrC, supra note 63 (citing Alta Deena Dairy's website reading "No
rBST in our products mean better and healthier cows.").
65. Letter from Mark K. Engle, FTC Associate Director, to Jodie Z. Bernstein &
Dana B. Rosenfeld re Monsanto Company Complaint on rBST-Related Claims
(Aug, 21, 2007), available at www.ftc.gov/os/closings/staff/070821monsanto.pdf.
66. Id. FTC staff did identify some isolated instances of companies making un-
founded health and safety claims on web sites. Id. After notification by the FTC,
the companies pledged to revise their marketing materials. Id.
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vestigation and enforcement action regarding rBST-free production
claims .67
Failing to restrict rBST-free production claims at the FTC level,
rBST proponents adopted yet another strategy to protect their mar-
ket share - influence state legislatures/agencies to adopt restrictions
on rBST-free production claims - an opposite approach to the Ver-
mont statue challenged in Amestoy.
D. State Regulation of rBST Labeling
Two of the largest dairy producing states - Pennsylvania and
Ohio 8 - have embarked on an rBST labeling journey similar to Ver-
mont's earlier attempt, but seeking to accomplish the opposite re-
sult - restrict diary producers ability to label their products as pro-
duced without the use of rBST. A brief discussion of the Pennsyl-
vania and Ohio proposals follows.
In 2007, Pennsylvania proposed outlawing all advertising and
labeling statements that indicate that a dairy product was not de-
rived from an rBST-treated cow. 9 Dennis Wolff, the state's Agricul-
ture Secretary, justified the action on fears that such labels implied
that rBST treated products were unsafe.7 ' Relying on the FDA's
finding that rBST-derived products are indistinguishable from un-
treated dairy goods, Wolff noted that so-called "rBST-free" products
were unjustifiably commanding a higher price in the market.
71
Some dairy producers and consumer advocates in the state took
umbrage with the proposed rule. They argued that the inability to
label their product would unfairly censor some producers while de-
nying consumers the information they need to make an informed
purchase.7 ' The state countered that the FDA has approved rBST
and has not found any distinguishable concerns in products derived
from treated animals. Furthermore, because no test exists to de-
67. Id.
68. See Don P. Blaney, The Changing Landscape of U.S. Milk Production, USDA,
ERS Statistical Bulletin No. 978, Table 2 (June 2002) available at
http://www.ers.usda.gov/publications/sb978/sb978.pdf (listing Pennsylvania and
Ohio as the 4th and 11th largest dairy producing states, respectively).
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tect rBST use, producers operated merely on an unverifiable "honor
system" in making claims regarding the hormone."
Following intense protest, Pennsylvania governor Ed Rendell
initiated a review of the labeling decision. The regulations, origi-
nally effective January 1, 2008, were put on hold amid the consumer
outcry and threats of lawsuits against the state.76 Two weeks later,
the Pennsylvania Department of Agriculture issued revised milk la-
beling standards allowing limited rBST-free production claims so
long as the label also included a disclaimer relating to the lack of a
difference with milk products from cows treated with rBST."
While Pennsylvania tried to resolve the issue by prohibiting dis-
closure altogether, Ohio sought to dictate the specific manner in
which producers could disclose the absence of rBST use. In Febru-
ary 2008, the Ohio Department of Agriculture issued rules'8 reinter-
preting existing Ohio statutes for food labels79 and the sale of dairy
products." The order, purporting to combat the "mislabeling of
dairy products" and to create uniformity in dairy labeling across the
state, prohibited "rBST-free" or "No Artificial Hormones" label
claims as false and misleading.' The new rule similarly bans pro-
duction claims such as "this milk is from cows not supplemented
with rBST" unless the labeling entity complies with two additional
provisions: (1) verify the accuracy of the claim with documentation
such as signed affidavits, farm weight tickets and plant audit trails,
and (2) include the disclaimer from the FDA's 1994 Interim Label-
ing Guidance: "The FDA has determined that no significant differ-
74. Scolforo, supra note 28.
75. Daniel Malloy, Pa. Dairy Label Rule Shelved, PITTSBURGH POST-GAZETTE, Nov.
28, 2007, at p. A-1.
76. Id.
77. Pennsylvania Dept. of Agriculture, Revised Standards and Procedures for the
Approval of Proposed Labeling of Fluid Milk (Jan. 17, 2008), available at
http://www.idfa.org/reg/labeling/ohio/exhibit_016.PDF (on file with the author).
78. See OHIO ADMIN CODE 901:11-8-01 (2008) (Dairy labeling) available at
http://www.ohioagriculture.gov/Admn/News/2008/news-admn_041408_RBST%
20Revised%2ORule%2OApril%201 1.pdf.
79. See OHIO REV. CODE ANN. § 3715.60 (2005) (misbranding of food products).
80. See OHIO REV. CODE ANN. § 917.05 (2004) (dairy products).
81. OHIO ADMIN CODE 901:11-8-01(C) (2008); see also Mark S. Jordan, Milk Label-
ing Issue Proceeds to State Legislature, MOUNT VERNON NEWS, Mar. 24, 2008 (describ-
ing why the Ohio Farm Bureau Federation believes that a more detailed disclaimer
should be required on dairy products utilizing absence labeling); Clarisse Doulaud,
Ohio Again Modifies Dairy Labeling Rule, FOOD NAVIGATOR USA, Apr. 25, 2008,
available at http://www.foodnavigator-usa.com/Legislation/Ohio-again-modifies-
dairy-labeling-rule.
82. OHIOADMIN CODE 901:11-8-01(B)(1) (2008).
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ence has been shown between milk derived from rBST-
supplemented and non-rBST supplemented cows."83  Producers
must print the disclaimer in no smaller than seven point font, con-
tiguous with the initial label claim.84 The regulation also dictates the
style, case, and color of the disclaimer - restrictions that are much
more specific than required by other states that have passed similar
regulations."
The International Dairy Foods Association ("IDFA"), the lead
plaintiff in the Amestoy litigation challenging the Vermont rBST label-
ing statute, immediately filed a complaint seeking a declaration that
the Ohio rules violated, inter alia, the First and Fourteenth Amend-
ments, as well as the Commerce Clause.88 The IDFA argued that the
Ohio statute silences dairy producers and prevents consumers from
receiving accurate information." Accordingly, the lawsuit seeks an
immediate injunction and an order declaring the law unconstitu-
tional under the first and fourteenth amendments and the dormant
commerce clause of the United States Constitution." In support,
IDFA claimed that the Ohio statute is more restrictive than is neces-
sary to advance the purported state interest and that the specifics in
the statute make the rule unworkable and unduly expensive to many
dairy producers. Compliance with the new rules would also place a
substantial burden on the interstate shipment of dairy products."
For example, ice cream producer Ben and Jerry's complained that
the new regulations would cost the company more than $250,000,
placing the company at a competitive disadvantage to those produc-
ers distributing solely within the state of Ohio." Citing the excessive
costs of compliance, IDFA claims that producers may be forced to
simply drop their rBST-free claims rather than face the task of com-
porting to the new rule. As of this writing, the parties are waiting
for a ruling on IDFA's Motion for Summary Judgment.3
83. OHIO ADMIN CODE 901:11-8-01(B)(2) (2008).
84. Id.
85. OHIO ADMIN CODE 901:11-8-01 (2008); see also Business Wire, supra note 44.
86. See Complaint, International Dairy Foods Ass'n v. Boggs, U.S. Dist. Ct. S.D.
Ohio, available at http://www.idfa.org/reg/labeling/ohio/ohio-idfa-complaint_
0630.pdf. (on file with the author).
87. Id.
88. Id.
89. Id. at para. 79-83.
90. Id.
91. Business Wire, supra note 44.
92. Complaint, supra note 86, at 82.
93. IDFA Reply Reaffirms Members' Right to Label (Sept. 18, 2008) available at
http://,A-ww.idfa.org/news/stories/2008/09/ohio-0918.cfm.
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E. Future rBST Labeling Skirmishes
Monsanto's sale of its Posilac brand to Elanco" raises many
questions regarding the future of rBST labeling battles. In its press
release following the choice to pursue a divestiture of Posilac, Mon-
santo explained that it still enthusiastically backed the viability of the
product and its future sales, but decided to sell the brand in order
to focus on their core seeds and traits business.95
While it is not clear how aggressively Elanco will combat the
"rBST-free" labels alleged by Monsanto to be misleading, Elanco
reportedly supports labels that simply inform consumers of the
presence or absence of the hormone without making disparaging
remarks regarding quality or composition." Along with their press
release announcing their acquisition of the Posilac brand, Elanco
issued a statement outlining its position on dairy products with the
"rBST-free" label. Elanco claims that, "[w]hether produced by rbST-
supplemented or non-supplemented dairy cows, the milk is the
same. Elanco supports consumers having the opportunity to make
well-informed food choices, as well as the ability of dairy producers
to make decisions about which approved production technologies
are right for their herds."97 In response to claims that organic and
so-called "rBST-free" products increasingly are in demand, Elanco
notes that worldwide demand for dairy products continues to ex-
ceed available supply and rBST will allow farmers to more efficiently
produce their products and respond to the market increase in dairy
demand.98
If nothing else, the three pronged approach of its predecessor,
Monsanto, to combat allegedly misleading product labels and pre-
94. Press Release, Monsanto, Monsanto to Pursue Divestiture of Posilac (Aug. 6,
2008) available at http://monsanto.mediaroom.com/index.php?s=43&item=626.
95. Id. (quoting Monsanto Executive Vice President Carl Casale, "[w]hile
POSI[AC is a strong product for the business, we believe repositioning the busi-
ness with a strategic owner will allow Monsanto to focus on the growth of its core
seeds and traits business while ensuring that loyal dairy farmers continue to receive
the value of POSILAC in their operations ... ").
96. Elanco Posilac Acquisition: Frequently Asked Questions, ELANCO, available at
http://www.mids.net/elanco/PosilacAcquisitionFAQs.pdf.
97. Id.
98. See id. (claiming that "[w]hile there is some demand for dairy products pro-
duced using various management practices, the reality is that the global demand for
all dairy products is increasing and will exceed the available supply. That's why it's
so important for dairy farmers to have safe, approved technologies available to help
them to produce highly nutritious dairy products in ways that use fewer natural
resources.").
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serve its market penetration presents an informative case study in
food product marketing. Directly challenging adverse state labeling
rules in court, applying pressure to companies promoting competi-
tive products via lawsuits or complaints to government regulators,
and working to pass favorable legislation in states with a history of
support for large-scale agriculture is a three-part strategy that other
firms could adopt, perhaps in modified form, to address future,
controversial product labeling practices. For example, food irradia-
tion, discussed in the last issue of this update,"0 could present a simi-
lar confluence of legal issues and consumer concerns that would call
for a variety of strategies to protect market share.
II. BISPHENOL A REGULATION AND INDUSTRY RESPONSE
Companies use bisphenol A (BPA) to manufacture epoxy resins
and polycarbonate plastics commonly used in baby bottles, food and
drink containers (including sport bottles), and dentistry com-
pounds.'0 When used in bottles and food containers, BPA can leach
from the product, leading to unintended ingestion in small quanti-
ties. ° ' Due to the popularity of containers made with the compound,
it is perhaps not surprising that at least some concentration of BPA
has been detected by urinalysis in as much as 95% of the U.S. popu-
lation.' 2 While it is generally undisputed that most humans have at
least traces of BPA concentrations in their system, stakeholders dis-
pute its effects on human health.' 3 More than 100 studies have
shown that BPA has harmful effects in animal lab tests even when
administered in very low concentrations."' A 2007 Environmental
Working Group (EWG) study found that BPA was present at unsafe
levels in 11 percent of canned foods and in one-third of infant for-
99. A. Bryan Endres, United States Food Law Update: Food Safety Planning Attribute
Labeling, and the Irradiation Debate, 4 J. FOOD LAW & POLICY 129, 149-153 (Spring
2008).
100. Antonia M. Calafat et al., Urinary Concentrations of Bisphenol A and 4-
Nonylphenol in a Human Reference Population, 113 ENVTL. HEALTH PERSP. 391, 391
(2005); Health Highlights, WASHINGTON POST, Aug. 16, 2008,
http://www.washingtonpost.com/wp-dyn/content/article/2008/08/16/AR200808
1600754.html?nav-hcmodule (last visited Feb. 12, 2009).
101. Calafat, supra note 100, at 391.
102. Id. Calafat et al.'s study notes that "[b]ecause of the widespread use of BPA,
the potential for human exposure is high." Id.
103. Liz Szabo, FDA Reviewing Plastic Ingredient BPA, USA TODAY, Apr. 27, 2008
(noting the conflicting opinions regarding BPA safety by many scientific studies and
those relied upon by the Food and Drug Administration).
104. Id.
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mulas. °5 Despite calls to reconsider BPA regulation, the U.S. Food
and Drug Administration (FDA) has asserted repeatedly that prod-
ucts containing BPA are safe.' 6
BPA is one of the leading high production volume chemicals
produced in the United States, with more than one billion pounds
produced annually.' 7 For over twenty years, an epoxy resin made
with BPA has been used as a liner for the interior of the majority of
cans.' 8 In 1997, studies focusing on the health effects of BPA began
with some regularity, with 116 being completed in the following
eight years.'0 In addition to BPA's potential adverse health effects,
the Canadian government has cited possible harm to fish and other
aquatic organisms in regulatory proceedings."'
Until recently, data on BPA's possible human health effects has
derived mainly from rodent and non-human primate studies. In
September 2008, the American Medical Association (AMA) pub-
lished a study using human urinalysis with a sample size of over
1,400 people."' While the study's authors note that further research
105. ENVTL. WORKING GROUP, BISPHENOL A: Toxic PLASTICS CHEMICAL IN CANNED
FOOD (2007), available at http://www.ewg.org/node/20928/print (concluding that
of the foods tested, chicken soup, infant formula, and ravioli contained BPA levels
of highest concern, and claiming that "a single serving contained enough BPA to
expose a woman or infant to BPA levels more than 200 times the government's
traditional safe level of exposure for industrial chemicals. The government typically
mandates a 1,000- to 3,000-fold margin of safety between human exposures and
levels found to harm lab animals, but these servings contained levels of BPA less
than 5 times lower than doses that harmed lab animals.").
106. FOOD & DRUG ADMIN., DRAFT ASSESSMENT OF BISPHENOL A FOR USE IN FOOD
CONTACT APPLCATIONS 37 (Aug. 8, 2008) (stating the agency's finding that "the
utility or relevance of a portion of the current body of data on BPA to human safety
assessment for food contact substances has not been established" and reiterating its
past finding of the compound's safety) [hereinafter Draft Assessment].
107. EWG, supra note 105.
108. Ian Austen, Bottle Maker to Stop Using Plastic Linked to Health Concerns, N.Y.
TIMES, Apr. 18, 2008, at C1. The epoxy resin is used in cans to extend the shelf life
of products and to ensure the metal used in the can does not taint the flavor of the
food or drink. Id.
109. Lyndsey Layton, Studies on Chemical in Plastics Questioned, THE WASHINGTON
POST, Apr. 27, 2008, at A01 (noting that many of the studies conducted between
1997-2005 researched the effects of low concentrations of BPA). Ninety percent of
the studies funded by the government linked a variety of health concerns to BPA
exposure, while none of the industry-funded studies reported such a link. Id.
110. Press Release, Health Canada, Government of Canada Takes Action on An-
other Chemical of Concern: Bisphenol A (Apr. 18, 2008) available at
http://www.hc-sc.gc.ca/ahc-asc/media/nr-cp/_2008/2008_59-eng.php.
111. lain A. Lang et al., Association of Urinary Bisphenol A Concentration with Medi-
cal Disorders and Laboratory Abnormalities in Adults, 300J. AM. MED. ASS'N 1303, 1303
(2008).
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is necessary to prove causality, "2 the study does report that mean
BPA concentrations were elevated in individuals with cardiovascular
diseases, clinically abnormal concentrations of liver enzymes, and
diabetes."3 The authors caveat that a prolonged study, rather than
single measurements, would best measure the possible serious ef-
fects of long-term, low-dose BPA exposure."'
At the same time the AMA study issued, the U.S. Department of
Health and Human Services released its final report through the
National Toxicology Program (NTP) examining the human repro-
ductive and developmental effects of BPA exposure. The NTP
notes that it "has some concern for effects on the brain, behavior, and
prostate gland in fetuses, infants, and children" resulting from low-
dose exposure to BPA."' The NTP's concern for BPA's effects on
mammary glands and early puberty for fetuses, infants, and chil-
dren, and the risk to non-occupationally exposed adults, on the
other hand, are stated as "minimal" and "negligible."..7 Presenta-
tions at the American Society for Reproductive Medicine's Novem-
ber 2008 annual meeting, however, indicate that BPA "could pre-
vent successful in vitro fertilization, or the ability of embryos to at-
tach to the uterus.""11
8
A. U.S. Regulation of BPA
1. The Food and Drug Administration (FDA)
The AMA and NTP studies placed increased pressure on the
FDA to tighten regulations on the use of BPA in food and drink
packaging. Although FDA historically has stood by its claim that
products manufactured with and containing BPA are safe at normal
exposure levels, FDA announced the formation of a task force which
reviewed new research and information on BPA beginning in April
112. Id. at 1309.
113. Id. at 1305-1307.
114. Id. at 1308.
115. U.S. DEP'T OF HEALTH AND HUMAN SERVICES, NTP-CERHR MONOGRAPH ON
THE POTENTIAL HUMAN REPRODUCTIVE AND DEVELOPMENTAL EFFECTS OF BISPHENOL A
(Sept. 2008).
116. Id. at 38-39 (emphasis original).
117. Id.
118. Steven Reinberg, Chemical in Plastics May Cause Fertility Problems, THE
WASHINGTON POST, Nov. 13, 2008, http://www.washingtonpost.com/wp-
dyn/content/article/2008/11/13/AR2008111303289.html (last visited Feb. 10,
2009).
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2008."9 Two months later, in June 2008, FDA charged a subcommit-
tee of its Science Board to organize a public meeting to review the
task force reports.'0
On August 14, 2008, FDA issued its Draft Assessment of
Bisphenol A For Use in Food Contact Applications, which focused
on the NTP's concerns.12' Based on the definition of safety for food
additives contained in the federal regulation,22 FDA concluded in
the Draft Assessment that "an adequate margin of safety exists for
BPA at current levels of exposure from food contact uses, for in-
fants and adults. ''2. FDA noted that the regulatory definition of
safety for food additives does not guarantee "certainty of absolute
harmlessness" and that such a standard would be "scientifically im-
possible to establish.'21 4 The Draft Assessment concluded that re-
cent reports were "insufficient to provide a basis to alter the
NOAEL [no observed adverse effect level] used to calculate the
margin of safety," and proposed a "tiered testing strategy in order to
decrease the uncertainties surrounding this assessment of BPA ex-
posure from the use of food contact materials.'22  The first tier
would involve a short-term analysis to determine whether additional
toxicology studies (Tier 2) are necessary. 12 The proposed research
aims to gather data such as rodent PK and toxicity data, biomonitor-
ing data, estimated daily intake data, and BPA toxicity studies in
non-human primates.'27
The FDA Science Board Bisphenol A Subcommittee held its
public meeting on September 16, 2008, at which FDA officials fur-
ther explained the conclusions and recommendations contained in
119. Consumer Update, FDA, Safety and Food Packaging: Bisphenol A (BPA)
(Aug. 19, 2008), available at http://www.fda.gov/consumer/updates/
foodpackaging081908.html.
120. Id.
121. Draft Assessment, supra note 106, at 2.
122. Id. at 3 (citing 21 C.F.R. § 170.3(i) (2008)).
123. Id. at 36.
124. Idat 2.
125. Id.
126. Id. at 37.
127. Dr. Laura Tarantino, Office Director, FDA Center for Food Safety and Ap-
plied Nutrition, Office of Food Additive Safety, Powerpoint Presentation to the
Subcommittee of FDA Science Board: Draft Assessment of Bisphenol A for Use In
Food Contact Applications (Sept. 16, 2008), available at http://www.fda.gov/
ohrms/dockets/ac/08/slides/2008-0038s1-01 .pdf.
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the Draft Assessment.12 1 Interested parties submitted over 200 writ-
ten comments to the Subcommittee. Several stakeholders criti-
cized the FDA's overreliance on two industry-sponsored studies and
discount of the NTP study, Canadian Government conclusions, and
the consensus statement of 38 BPA experts from around the world
who have expressed "great concern with regard to adverse effect in
humans... ,,0 Participants urged the FDA to take a precautionary
approach and reconsider its conclusions in the Draft Assessment.
Shortly after the public meeting, a panel of scientists from govern-
ment and academia released a report highly critical of the FDA's
Draft Assessment, alleging that FDA has "not take[n] into considera-
tion scores of studies that have linked [BPA] to prostate cancer, dia-
betes and other health problems in animals....
Representative John Dingell wrote a letter to FDA Commis-
sioner Andrew von Eschenbach on October 18, 2008, alleging that
FDA's reliance on two industry studies in its decision not to further
regulate BPA was motivated, at least in part, by a $5 million dona-
tion to the research center of the BPA Advisory Panel chair by a
major medical device manufacturer.32 The letter requests answers
within two weeks to several questions regarding conflict of interest
and its effect on future use of good laboratory practices in evaluat-
ing scientific studies. 3'
2. Legislative Initiatives at the Federal, State and Local Level
In the absence of regulatory action by FDA, Congress and sev-
eral state legislatures are taking a more aggressive stance against the
use of BPA. U.S. Representative Edward Markey (D-MA) has intro-
duced a bill that would ban BPA from all food and beverage packag-
ing 180 days after enactment of the bill.134 A bill introduced in the
128. Hearing Transcripts, FDA Science Board Bisphenol A Subcommittee (Sept.
16, 2008), available at http://www.fda.gov/ohrms/dockets/ac/oc8.html#
ScienceBoard.
129. Id. at 115.
130. Id. at 118.
131. Annys Shin, BPA Ruling Flawed, Panel Says, THE WASHINGTON POST, Oct. 29,
2008, at A13.
132. Letter, John D. Dingell (D-Mich.) to FDA Commissioner Dr. Andrew von
Eschenbach (Oct. 15, 2008), available at http://energycommerce.house.gov/
investigations/Bisphenol. 101508.FDA.Itr.pdf.
133. Id.
134. Ban Poisonous Additives Act of 2008, H.R. 6228, 110th Cong. (2008).
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Senate by Charles Schumer (D-NY) "5 focuses on controlling BPA in
toys and related products intended for use by children under the
age of seven. ' Efforts at the state level similarly have emphasized
protecting children from BPA ingestion. 41 measures relating to
BPA are pending in 13 states, including 33 bills that propose ban-
ning BPA in consumer products (particularly toys and other child
care products used by small children), seven that call for additional
studies on BPA risks, and one that would require labeling. '37 In
April 2008, Maine took what can be seen as the first state-level step
to limit BPA use when legislators overwhelmingly voted to require
regulators to prioritize chemicals of concern in children's products -
which could include BPA - and granted regulators the authority to
require safer alternatives.' 8 Many state legislatures have attempted,
or are attempting to, regulate Bisphenol A as well, particularly relat-
ing to childhood exposure to BPA, including California,"9 Connecti-
cut,H1° Hawaii, 4 ' Illinois,'42 Maryland, "3 Massachusetts,14 1 Minnesota,4 ,
New Jersey,'6 New York, 7 Pennsylvania,' 8 Rhode Island,4 and Ver-
mont."°
In May of 2006, the City of San Francisco became the first ju-
risdiction to ban the sale of toys and childcare articles containing
135. BPA-Free Kids Act of 2008, S. 2928, 110th Cong. (2008). Introduced by Sen.
Charles Schumer and referred to the Committee on Commerce, Science, and
Transportation on April 29, 2008. Id.
136. Id.
137. George G. Misko, Governmental Initiatives Against Specific Chemicals:
Annual Food Packaging Seminar (Oct. 22, 2008), available at http://printpack.
com/BPAFiles/Governmental%201nitiatives%20Against%20Specific%20Chemicals.
pdf.
138. L.D. 2048 (Me. 2008).
139. S.B. 1713 (Cal. 2008); A.B. 1108 (Cal. 2007). The Senate passed S.B. 1713,
but failed to pass in the Assembly. The California Office of Environmental Health
Hazard Assessment (OEHHA) has begun the process of considering listing BPA as
a toxicant pursuant to Proposition 65. No. 3-Z Cal. Regulatory Notice Reg. 70 (Jan.
18, 2008).
140. S.B. 527 (Conn. 2008); H.B. 5601 (Conn. 2008).
141. H.B. 2187, the bill H.B. 2449, and S.B. 2239 (Haw. 2008).
142. H.B. 4744; H.B. 5705; S.B. 2868 (Ill. 2008).
143. H.B. 833 (Md. 2008).
144. S.B. 545, S.B. 2340, H.B. 259 (Mass. 2007).
145. S.F. 1858 and H.F. 2100 (Minn. 2008).
146. A. 2112, A. 2332, and S. 1428 (N.J. 2008).
147. A. 06829 and S. 06058 (N.Y. 2007).
148. H.B. 1924 (Pa. 2007).
149. H.B. 7812, H.B. 7813, S.B. 2381 (R.I. 2008).
150. H. 858 (Vt. 2008) (no committee action).
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BPA that are intended for use by a child under three years of age.' '
The Ordinance concludes that BPA "has been shown to have hor-
mone-disrupting effects and is used in many products designed for
children....
B. Other Government BPA Regulation
1. Canada
Canada is currently in the process of eliminating childhood ex-
posure to BPA, minimizing BPA releases into the environment, and
is studying the prospect of regulating BPA migration from food
packaging. Canada made much progress toward this goal in 2008.
In April, Canada released its draft screening assessment for
BPA, a first step to BPA's listing as a Domestic Substance under the
Canadian Environmental Protection Act of 1999 (CEPA)"' The
draft assessment proposed that BPA "be considered as a substance
that may be entering the environment in a quantity or concentration
or under conditions that constitute a danger in Canada to human
life or health."'54 Upon closure of the comment period, Canada is-
sued its final screening assessment. 5 The final assessment con-
cluded that BPA may be endangering human life or health, and that
it may be entering the environment at levels that may have an im-
mediate or long-term effect on the environment or biological diver-
sity."6 The government proposed on October 18, 2008 to place BPA
151. S.F., Cal., Health Code, Chap. 34 (2006), available at http://www.sfgov.org/
site/uploadedfiles/bdsupvrs/ordinances06/o0120-06.pdf.
152. Id.
153. Can. Gaz. Part I, Vol. 142, No. 16, 1105-1109 (Apr. 19, 2008). The Canadian
Environmental Protection Act requires the Ministers of Environment and Health to
set priorities for identifying substances that present the greatest potential for expo-
sure to humans or that are persistent or bioaccumulative, to determine whether the
substance is inherently toxic to humans or non-human organisms, and to conduct a
risk assessment. Environment Canada, A Guide to Understanding the Canadian
Environmental Protection Act, 1999, available at http://www.ec.gc.ca/CEPARegistry/
theact/guideO4/s5.cfm.
154. Can. Gaz. Part I, Vol. 142, No. 16, 1108 (Apr. 19, 2008).
155. Environment Canada and Health Canada, Screening Assessment for the
Challenge [Bisphenol A] (Oct. 2008), available at http://www.ec.gc.ca/
substances/ese/eng/challenge/batch2/batch2_80-05-7_en.pdf.
156. Environment Canada and Health Canada, Proposed Risk Management Ap-
proach for [BPA] (Oct. 2009), available at http://www.ec.gc.ca/substances/ese/
eng/challenge/batch2/batch2_80-05-7 rm en.pdf [hereinafter Proposed Risk Man-
agement Approach].
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on Schedule 1 of the CEPA as a toxic substance.5 7 Upon being de-
clared toxic, the government either develops risk management
measures or begins a process of eliminating the substance below
measurable levels. Canada is proposing a ban on the importation,
sale and advertising of polycarbonate baby bottles made with BPA,
and "will develop stringent migration targets for [BPA] in infant
formula cans.' 15 It is also exploring "the option of establishing
stringent migration targets for [BPA] in canned foods in general"
and developing regulations "to prevent or minimize releases to the
environment."'" Future monitoring efforts will include collecting
and analyzing human urine samples and refining exposure estimates
from all pre-packaged foods, including canned foods.'"' After a pe-
riod of comment and consultation, Canada estimates that it will pub-
lish final regulations no later than April 2012."'
2. The European Union (EU)
The use of BPA in baby and water bottles in the EU is governed
by Commission Directive 2002/72/EC, relating to plastic materials
and articles that come into contact with foodstuffs.' The EU has
not banned BPA in these products outright. Instead, the Directive
sets a migration value for BPA based on a 2006 risk assessment by
the European Food Safety Agency (EFSA)." In light of the Cana-
dian findings, the EFSA recently reconsidered its 2006 opinion on
the safety of BPA." A scientific panel found that previous exposure
levels considered in its 2006 European Union Risk Assessment Re-
157. Can. Gaz. Part I., Vol. 142, No. 42, 2793-2796 (Oct. 18, 2008).
158. Environment Canada, The Canadian Environmental Protection Act (CEPA
1999) and the Assessment of Existing Substances, available at http://www.ec.gc.ca/
CEPARegistry/geneinfo/fact_08cfm.
159. Proposed Risk Management Approach, supra note 158 at 13-14.
160. Id. at 14
161. Id. at 15-16.
162. Id. at 17.
163. Commission Directive 2002/72, 2002 O.J. (L220) (EC).
164. European Food Safety Authority, Opinion of the Scientific Panel on Food
Additives, Flavourings, Processing Aids and Materials in Contact with Food on a
request from the Commission related to [BPA], Nov. 29, 2006, available at
http://www.efsa.europa.eu/cs/BlobServer/ScientificOpinion/afc op ej428_bpa_
op-en,3.pdf?ssbinarytrue.
165. European Food Safety Authority, Toxicokinetics of Bisphenol A: Scientific
Opinion of the Panel on Food additives, Flavourings, Processing aids and Materials
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port remained valid for fetal, neonatal, and adult human exposure. '
The Commission concurred with EFSA's conclusion. 7 In reaffirm-
ing their 2006 opinion that BPA exposure did not rise to the level
warranting prohibition, the EFSA noted differences between the
effects of BPA on humans and animals, finding that research from
animal studies did not warrant significant concern for human
health. '8 The EFSA took note of Canada's reliance on the National
Toxicology Program's report, but criticized it as being "limited in
rigour, consistency and biological plausibility."'6  Any other restric-
tions of BPA-for example food and beverage containers-is the re-
sponsibility of each member state in the absence of E.U. regulation.
3. Norway
Although not a member of the EU, the Northern European na-
tion of Norway lists BPA on its "priority substances" list, which tar-
gets the chemical for substantial reduction in consumer products by
2010."' In July 2008, the Norwegian Pollution Control Agency
(NPCA) recommended that the Ministry of the Environment de-
velop regulations that severely limit concentration limits for BPA in
consumer products. 7' Food packaging is exempt from the regula-
tions, however.'72
166. Id. at 6-10 (citing the 2006 EFSA Opinion, supra note 61).
167. Remarks of Carl Schlyter, EUR. PARL. DEB. (Question by the European Par-
liament to the Commission regarding new research concerning bisphenols) (Oct.
23, 2008), available at http://www.europarl.europa.eu/sides/getDoc.do?pubRef=-
//EP//TEXT+CRE+20081023+ANN-0 1+DOC+XML+VO//EN&Ianguage=EN&de-
tail=H-2008-0770&query=QUESTION.
168. Press Release, European Food Safety Authority, EFSA updates advice on
bisphenol (Jul. 23, 2008), available at http://www.efsa.europa.eu/EFSA/efsa-locale-
1178620753812_1211902017373.htm. The EFSA noted that there are significant
differences between humans and rodents and their ability to metabolize and ex-
crete BPA from their systems. Id. It further observed that humans can safely and
rapidly metabolize and eliminate low doses of Bisphenol A from their bodies. Id.
169. Id.
170. Regulations Relating to the Classification, Labeling, etc. of Dangerous Prod-
ucts, FOR 2002-07-16-1139, available at http://www.lovdata.no/for/sf/ai/xi-
20020716-1139.html (in Norwegian); State of the Environment Norway, List of
Priority Substances, available at http://www.environment.no/Tema/Kjemikalier/
Kjemikalielister/Prioritetslisten/.
171. Letter from The Norwegian Pollution Control Agency to the Ministry of the
Environment (Jul. 8, 2008), available at http://www.sft.no/nyheter/brev/
forbrukerprodukterforslag_MD080708_english.pdf.
172. News release, RoHS: Norway-new draft regulation hazardous substances
(Sept. 3, 2008), available at http://www.accerio.com/allnews.php?nw-68; http://
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C. Industry Response
Several manufacturers and retailers have made the voluntary
decision to remove BPA from their products. Wal-Mart Stores, Inc.
pulled all baby bottles, pacifiers, water bottles, and food containers
containing Bisphenol A from its Canadian stores in April 2008 and
will expand its policy to U.S. locations by early 2009. 173 Toys "R" Us
and Babies "R" Us are working with manufacturers to phase out all
baby products and feeding products by the end of 2008."7 In its
announcement of the new corporate policy, the retailer noted that
Bisphenol A has not been banned by the FDA but attributes the
store's action to growing consumer concerns. 75 The popular water
bottle producer Nalgene also announced in April 2008 that it would
stop using BPA in its products. '7c In the announcement, the com-
pany's general manager indicated that consumers have demanded
BPA-free alternatives and claimed that "[c]onsumer demand for
BPA products had largely dried up.' 77
Government officials continue to pressure industry to remove
BPA from consumer products, particularly those used by children.
Congressmen John Dingell and Bart Stupack have written letters to
four industry representatives requesting voluntary removal of BPA
from infant formula packaging.'78 Responses from two companies
indicate that they are working on finding alternatives to BPA in
these products.'79
www.rohs-international.com/site files/rohs-international.com/Draft regulationsfor
_NorwegianPoHS.pdf (english translation of draft regulations).
173. Ylan A. Mui Wal-Mart to Pull Baby Bottles Made with Chemical BPA, THE
WASHINGTON POST, Apr. 18, 2008 at DOI.
174. Toys "R" Us, General Safety Questions, http://www2.toysrus.com/safety/
safetyFAQs.cfm (last visited October 19, 2008).
175. Id.
176. Austen, supra note 108.
177. Id.
178. Letter, Representatives John D. Dingell (D-Mich.) and Bart Stupack (D-Mich.)
to industry representatives regarding BPA in infant formula packaging (May 6,
2008), available at http://energycommerce.house.gov/Press_110/110-ltr.050608
.4companies.BPA.pdf.
179. See Letter, Kurt Schmidt to Chairman Dingell and Chairman Stupack (May
20, 2008) (Nestle response), available at http://energycommerce.house.gov/
images/stories/Documents/investigations/publichealth/Bisphenol.052008.respto
050608.Nestle.ltr.pdf; Letter, PBM Products, LLC to Chairman Dingell and Chair-
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Attorneys General Anne Milgram (NJ), Richard Blumenthal
(CT) and Joseph Biden, III (DE) have voiced concerns to eleven
children's product manufacturers who use Bisphenol A in their baby
bottles, infant formula packaging, and other similar products.18 In
his letter, Blumenthal claimed that credible evidence exists linking
BPA to numerous health problems and risks that are especially dan-
gerous to infants and young children.'81
Public pressure on manufacturers that use BPA in food and
drink products will continue to grow, particularly for products used
by young children. This may lead to more voluntary actions to re-
move BPA-containing products from store shelves. Legislative or
administrative regulation, or at the very least increased scrutiny, is
likely at the federal level with the new Obama Administration and a
fortified Democratic majority in Congress.
III. IN RE FARM RAISED SALMON CASES
Fish farmers, like producers of eggs,'82 can manipulate flesh
color by modifying the amount of various chemical dyes in fish
feed. '3 The intent behind the use of artificial coloring in raising
salmon is to duplicate the flesh color of wild salmon.'" In 2004,
consumers filed a class and representative action in California state
court alleging that several grocery stores violated state unfair label-
ing and consumer deception laws85 by selling artificially colored
180. Catherine Larking, States: Ban Bisphenol A in Baby Products, PHILA. INQUIRER,
Oct. 14, 2008, http://www.philly.com/inquirer/world-us/20081014_States_
Banbisphenol A in baby-products.html (last visited Feb. 10, 2009).
181. Press Release, Connecticut Attorney General's Office, Attorney General
Calls on Manufacturers to Stop Using Toxic Chemical in Baby Bottles, Formula
Containers (Oct. 13, 2008), available at http://www.ct.gov/ag/cwp/view.asp?
A=2341&Q=424834.
182. See W.L. Brown, The Influence of Pimiento Pigments on the Color of the Egg Yolks
of Fowls, THE J. OF BIOLOGICAL CHEMISTRY (1937), at 655, available at
http://www.jbc.org/cgi/reprint/122/3/655.pdf.
183. Farm Raised Salmon Cases, 175 P.3d 1170, 1173 n.4 (Cal. 2008) (noting that a
particular dye manufacturer offers to salmon farmers the "SalmoFan," which is
similar to a paint color wheel with assorted shades of pink to assist fish farmers in
selecting a flesh color for their harvested fish). The artificial colors added to the
farm raised salmon were asataxanthin and canthaxanthin. Id. at 1173.
184. See Id. at 1173.
185. Plaintiffs alleged violations of the California Unfair Competition Law (UCL)
(Bus. & Prof. Code § 17200 et seq.), Consumers Legal Remedies Act (CLRA) (Civ.
Code § 1750 et seq.), the false advertising law (Bus. & Prof. Code § 17500 et seq.),
the Sherman Food, Drug, and Cosmetic Law (Health & Saf. Code § 109875 et seq.),
and negligent misrepresentation. Id. at 1173-74.
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farmed salmon without disclosing the use of color additives. '86 In
addition to raising concerns about the potential risks of consuming
the artificial coloring agents, plaintiffs alleged that defendants vio-
lated the Federal Food, Drug and Cosmetic Act (FFDCA) and the
Sherman Food, Drug, and Cosmetic Act (Sherman Law)-the Cali-
fornia equivalent of the FFDCA.'87
Defendant grocery stores successfully demurred in the trial
court, and the California Court of Appeal for the Second District
affirmed.188 The Court of Appeal held that section 337(a) of the
FFDCA precludes private enforcement of the federal act. Accord-
ingly, plaintiffs' state law claims, predicated on violations of the
FFDCA, were preempted. 9 The Supreme Court of California, how-
ever, reversed.'9 ° A brief discussion of the case and its implications
follows.
Section 331(b) of the FFDCA prohibits the misbranding of
food. Food is misbranded if "[i]t bears or contains any ... artificial
coloring ... unless it bears labeling stating that fact..." '' Food and
Drug Administration (FDA) regulations'92 require that the use of
astaxanthin or canthaxanthin in farm-raised salmon as color addi-
tives must be labeled on the food, its container, and/or its wrapper
by name or through the use of a phrase an ordinary consumer
would be likely to read and understand, such as "Artificial Color
Added.' 9 3 As noted above, however, Section 337(a) of the FFDCA
precludes private enforcement of these FFDCA labeling provi-
sions."'
In 1990, Congress, via the Nutrition Labeling and Education
Act of 1990 (NLEA), amended the FFDCA.99 The NLEA amend-
ments, via explicit preemption of not identical state rules, standard-
ized, at the national-level, various food labeling provisions. One
such area of preemption was the labeling of color additives.' The
NLEA, however, authorized states to establish food labeling re-
186. Id. at 1173.
187. Id. at 1174.
188. Id. at 1174.
189. Id. at 1174.
190. Id. at 1184.
191. 21 U.S.C. § 343(k) (2008).
192. 21 C.F.R. § 73.35(d)(3) (2008); 21 C.F.R. § 73.75(d)(4) (2008).
193. 21 C.F.R. § 101.22(c) (2008).
194. 21 U.S.C. § 337(a); See also Farm Raised Salmon Cases, 175 P.3d at 1175-76.
195. Pub. L. No. 101-535 (1990), 104 Stat. 2353.
196. 21 U.S.C. § 343-1 (2006) (listing 21 U.S.C. § 341(k) (color additives) as one of
the preempted food labeling provisions).
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quirements identical to those contained in the FFDCA.'07 Califor-
nia's Sherman Law "incorporates all of the food labeling regulations
promulgated by the FDA, including those having to do with the use
of astaxanthin and canthaxanthin in the feeding of farmed
salmon." '98  Accordingly, under the California law, food is mis-
branded "if it bears or contains any ... artificial coloring ... unless its
labeling states that fact." '99 The label disclosing the addition of color
must be prominently placed and written in terms "as to render it
likely to be read and understood by the ordinary individual under
customary conditions of purchase and use.
'20 0
The core issue, therefore, in Farm Raised Salmon Cases was
whether § 337 precludes private claims predicated on a state law
identical to the FFDCA. °' The California Supreme Court found that
Congress, in enacting § 343-1 of the FFDCA, clearly intended to
allow the states to enact identical state laws, but remained silent as
to the remedies states could "provide for the violation of those laws,
such as private actions. 22" Looking beyond the language of the stat-
ute, the Court examined an uncodified provision of NLEA in which
Congress stated that NLEA "shall not be construed to preempt any
provision of State law, unless such provision is expressly preempted
under [section 343-1] of the [FDCA]." °3 Because Congress chose
not to supplant private claims based on state laws enacted pursuant
to NLEA, the Court held that the FFDCA should be interpreted to
allow states to provide a broad spectrum of private remedies."4
In concluding that § 343-1 permits private claims based on state
law, the Court also relied on decisions by the Supreme Court of the
United States interpreting similar statutory schemes. In Medtronic,
Inc. v. Lohr,°5 the Supreme Court interpreted the Medical Device
Amendments to the FFDCA, which, like NLEA, prohibits states
from enacting laws with requirements different from those of the
FFDCA 0 The Medtronic court held that the states were free to pro-
197. Farm Raised Salmon Cases, 175 P.3d at 1178.
198. Id. at 1178 (comparing Cal. Health & Saf. Code § 110100, subd. (a) with 21
C.F.R. §§ 73.35, 73.75).
199. Cal Health & Saf. Code § 110740 (2006).
200. Id. at § 110705.
201. Farm Raised Salmon Cases, 175 P.3d at, 1176.
202. Id. at 1178.
203. Pub. L. No. 101-535, § 6(c)(1) (Nov. 8, 1990).
204. Farm Raised Salmon Cases, 175 P.3d at 1179.
205. 518 U.S. 470 (1996).
206. See 21 U.S.C. § 360(k) (2006).
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vide for private remedies for violations of the state law provisions. 7
Similarly, in Bates v. Dow,08 the Court considered whether the Fed-
eral Insecticide, Fungicide, and Rodenticide Act (FIFRA), which
contains a provision barring states from imposing requirements dif-
ferent from those required under the Act, preempts private state law
actions. The Court held that "[t]he imposition of state sanctions for
violating state rules that merely duplicate federal requirements is
equally consistent with the text of [the Act].20° Indeed, the Supreme
Court of California noted that no court "has ever held that states
may not provide a private remedy for the violation of state laws im-
posing requirements identical to those imposed by federal law.
210
As noted by the California and United States supreme courts,
states have an historic role in regulating food product marketing,
including deceptive sales practices and labeling.21' The Farm Raised
Salmon Cases reinforces this strong history and should provide con-
sumers authority to enforce similar state-level food labeling rules in
instances in which federal regulators fail to act. In an era of increas-
ingly stretched budgets for regulatory oversight and enforcement,
there may be more reliance in the future on private attorney-general
actions. Observers of environmental law regard citizen suits as an
inherent part of the regulatory scheme.2  Whether this is the future
of food law, however, may depend on the cooperative culture of the
207. Medtronic, 518 U.S. at 495.
208. 544 U.S. 431 (2005).
209. Id. at 442.
210. Farm Raised Salmon Cases, 175 P.3d at 1182. The Court further considered
whether § 337 of the FFDCA impliedly preempted the state law claims. The Court
found that because the plaintiffs' claims did not seek to enforce the FFDCA, but
rather were predicated on violations of the Sherman Law, § 337 did not apply. Id.
at 1181-2. On remand, the Court of Appeal held that plaintiffs alleged sufficient
facts to state a cause of action for violation of the Consumers Legal Remedies Act
and that sustaining the demurrer on appeal was in error. Farm Raised Salmon Cases,
2008 WL 2070612.
211. Farm Raised Salmon Cases, 175 P.3d at 1176; Florida Lime & Avocado Growers
v. Paul, 373 U.S. 132, 144 (1963) (upholding avocado marketing restrictions and
observing that "the States have always possessed a legitimate interest in the protec-
tion of (their) people against fraud and deception in the sale of food products' at
retail markets within their borders").
212. Jefferson D. Reynolds, Defanging Environmental Law: Extracting Citizen Suit
Provisions Under Seminole Tribe v. Florida, 12 J. NAT. RESOURCES AND ENVIRONMENTAL
L. 71, 71 (1997) (noting importance of citizen suits to a variety of regulatory pro-
.grams, including environmental law); Jonathon H. Adler, Stand or Deliver: Citizen
Suits, Standing and Environmental Protection, 12 DUKE ENVIRONMENTAL L. & POL'Y
FORUM 39, 43-44 (2001) (discussing theory of citizen suits in environmental protec-
tion).
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food industry with its regulators and the desire for preventative
compliance measures rather than technology forcing ex ante gov-
ernment penalties. Whether this is a step in the right direction for
the food regulatory system, is a separate question left for another
day.13
IV. RESTAURANT REGULATION: CHALLENGES TO CALORIC CONTENT
MANDATES AND THE AMERICANS WITH DISABILITIES ACT
A. New York State Restaurant Association v. New York City
Board of Health
In January 2008, the New York City Board of Health adopted
New York City Health Code Section 81.50 ("Regulation 81.50" ).214
Regulation 81.50 requires restaurants with fifteen or more estab-
lishments nationally (offering meals standardized for portion size
and content) to post calorie content information in their menus and
on their menu boards:
215
"All menu boards and menus in any covered food service establishment
shall bear the total number of calories derived from any source for each
menu item they list. Such information shall be listed clearly and con-
spicuously, adjacent or in close proximity such as to be clearly associated
with the menu item.
21 6
On January 31, 2008, the New York State Restaurant Associa-
tion ("Association") filed a declaratory judgment action against the
New York City Board of Health ("Board") in the United States Dis-
trict Court for the Southern District of New York, alleging the Nu-
trition Labeling and Education Act of 1990 (NELA) preempted
Regulation 81.50 and that the Board's regulatory mandate violated
the First Amendment.217 On April 16, 2008, the District Court de-
nied the Association's motion for a preliminary injunction against
the enforcement of Regulation 81.50 and granted the Board's mo-
213. See e.g., Harold Kent, Of Citizen Suits and Citizen Sunstein, 91 MicH. L. REV.
1793, 1808 (1993) (arguing that "[e]mploying private attorneys general to combat
the risk of underenforcement also creates the risks of overenforcement and arbi-
trary rule"); Edward Brunet, Debunking Wholesale Private Enforcement of Environ-
mental Rights, 15 Harv. J. L. PUB. POL'Y 311 (1991) (criticizing over-reliance on pri-
vate citizen suits to protect the environment).
214. New York State Rest. Ass'n v. New York City Bd. of Health, No. 08 Civ. 1000,
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tion for summary judgment on the NLEA preemption issue."1 8 The
Association subsequently appealed the decision to the United States
Court of Appeals for the Second Circuit and moved in the trial
court for a stay of enforcement pending appeal.1 9
The District Court, pursuant to Federal Rule of Civil Procedure
62(c), balanced four factors in consideration of the stay: "(1)
whether the stay applicant has made a strong showing that he is
likely to succeed on the merits; (2) whether the applicant will be ir-
reparably injured absent a stay; (3) whether issuance of the stay will
substantially injure the other parties interested in the proceeding;
and (4) where the public interest lies. 22' The court ultimately denied
the stay pending appeal, holding that the Association had not dem-
onstrated a substantial possibility of success on either preemption or
First Amendment claim. 1
Despite the court's acknowledgement of the City and public's
strong interest in enforcement of Regulation 81.50, the court en-
tered an interim stay to permit the Association to request relief
from the Second Circuit. The court enjoined enforcement of Regu-
lation of 81.50 through April 25, 2008 and ordered that the Board
may not seek monetary finds for violations of Regulation 81.50
through June 6, 2008.
The Association appealed the District Court's decision on the
stay. On April 28, 2008, the Second Circuit denied to enter a stay,
but did extend the moratorium on issuing fines through July 18,
2008 and agreed to expedite the hearing.222 As of this writing, no
decision has yet been issued in the appellate court on the merits in
this case. Many, however, view this as a test case for future
state/local regulation of the restaurant industry. For example, Cali-
fornia recently passed similar legislation with a phased implementa-
tion/enforcement dates of July 1, 2009 for point of sale nutrition
brochures and December 31, 2010 for caloric posting on menus and
menu boards.12 4 The constitutional interpretations resulting from
218. Id. at*13.
219. New York State Rest. Ass'n v. New York City Bd. of Health, 545 F. Supp. 2d 363,
365 (S.D.N.Y. 2008).
220. Id. at 365-366 (quoting In re World Trade Ctr. Disaster Site Litig., 503 F.3d 167,
170 (2d.Cir. 2007)).
221. Id. at 366.
222. Id. at 369.
223. Order Denying Motion to Stay Pending Appeal, NO. 08-1892-cv (April 28,
2008), available at http://pubcit.typepad.com/clpblog/files/CA2staydenial.pdf.
224. S.B. 1420 (Ca. 2008), codified at CAL. HEALTH & SAFETY CODE § 114094.
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this Second Circuit case undoubtedly will influence industry delib-
erations regarding potential challenges to the California rules. 2
B. The Americans with Disabilities Act and Fast Food Restaurant Menus:
Camarillo v. Carrols Corp.
Alice Camarillo, a legally blind woman who is "able to read
enlarged writing at a very close distance, frequently patronized the
fast food restaurants.. owned and operated by the defendants. 2 6 At
each restaurant, Camarillo informed the employees that she could
not read the posted menu items and, because large print menus
were not available, requested that the employees read her the menu
options.227 Camarillo alleged that the restaurant employees read
only part of the menu to her, mocked and humiliated her, and
served patrons behind her in line prior to offering the limited assis-
tance. In response, Camarillo filed suit claiming defendants had
violated the Americans with Disabilities Act (ADA)29 and New York
state law.22  The United States District Court for the Northern Dis-
trict of New York dismissed her claims, holding that she failed to
allege sufficient facts to demonstrate an injury under the ADA.23'
Camarillo appealed to the United States Court of Appeals for
the Second Circuit.2 2 At issue on appeal was whether Camarillo had
sufficiently alleged that she was not afforded a full and equal oppor-
tunity to access the services at defendants' restaurants because they
did not provide large print menus or any other means to ensure
effective communication of the menu options."' Title III of the
ADA provides that "[n]o individual shall be discriminated against on
the basis of disability in the full and equal enjoyment of the goods,
services, facilities, privileges, advantages, or accommodations of any
place of public accommodation. 22 The ADA defines discrimination
as "a failure to take such steps as may be necessary to ensure that no
individual with a disability in excluded, denied services, segregated
225. See, e.g., Chain Leader, NCCR Disappointed by California Menu Labeling Law,
Sept. 30, 2008, available at http://www.chainleader.com/article/ca6600801.html.
226. Camarillo v. Carrots Corp., 518 F.3d 153, 154 (2d Cir. 2008).
227. Id. at 155.
228. Id.
229. 42 U.S.C. § 12182 (2000).
230. NY CLS Exec § 296.2(a) (2008).
231. Camarillo, 518 F.3d at 155.
232. Id. at 156.
233. Camarillo, 518 F.3d at 156.
234. 42 U.S.C. § 12182(a).
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or otherwise treated differently than other individuals because of
the absence of auxiliary aids and services .... ,. Further, imple-
menting regulations provide that "public accommodation[s] shall
furnish appropriate auxiliary aids and services where necessary to
ensure effective communication with individuals with disabilities.""23
The Second Circuit found Canarillo adequately pleaded that
defendants violated the ADA and that she had standing to pursue
her claims.2 37 Although restaurants are not necessarily required to
have large print menus, the court held that they are required to en-
sure effective communication of their menu options to individuals
with disabilities.23 The court found a reasonable inference from
Camarillo's complaint that defendants failed to adopt policies or
procedures to effectively train their employees to deal with disabled
individuals. Accordingly, defendants' employees' unwillingness to
effectively communicate the menu options to Camarillo sufficiently
stated a claim under the ADA.139 The court concluded that Cama-
rillo had standing to pursue her claims because she had alleged a
past injury; it was "reasonable to infer from her complaint that [the]
discriminatory treatment would continue" because defendants had
not adopted policies or provided training to ensure that disabled
individuals would not be excluded, denied services, segregated, or
otherwise treated differently than other individuals; and it was rea-
sonable to infer that she intended to return to the restaurants in the
future because of their proximity to her home.24° While Camarillo v.
Carrols Corp. may not be a ground-breaking case for regular practi-
tioners of civil rights/disability law, the court's particular application
of the ADA in the restaurant context is congruent with the increas-
ingly regulated and scrutinized nature of "fast food" restaurants,
whether it be mandated calorie disclosures,24' trans fat bans,24 2 zoning
restrictions"' or obesity litigation.24 Clearly, Americans increasingly
have a love-hate relationship with fast food.
235. Id. at 12182(b)(2)(A)(iii).
236. 28 C.F.R. § 36.303(c) (2005).
237. Camarillo, 518 F.3d at 156.
238. Id. at 157.
239. Id.
240. Id. at 158.
241. See supra notes 214-224.
242. David Burnett, Fast Food Lawsuits and the Cheeseburger Bill: Critiquing Con-
gress's Response to the Obesity Epidemic, 14 VA.J. SOC. POL'Y & L. 357, 367.
243. See Jackson S. Davis, Fast Food, Zoning & the Dormant Commerce Clause: Was it
Something I Ate?, 35 B.C. ENvr'L AFFAIRS L. REV. 259 (2008); Graham M. Catlin, A
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V. CONCLUDING THOUGHTS
Consumer protection issues comprised the majority of the sig-
nificant legal developments in food law in the first six months of
2008. Although a controversial topic since its introduction, rBST-
labeling rules entered a new phase during this time period, as states
with significant agricultural production-Ohio and Pennsylvania-
entered the labeling debate. Similarly, regulators and consumer
protection groups placed increased attention on the use of BPA in
food contact materials, a chemical with a long and prevalent history
of use in the United States. It is unclear at this time if the pending
change in the federal executive branch and increased Democratic
majority in Congress will change the government's approach to BPA
use and/or rBST labeling. Observers do expect the introduction of
several bills relating to these issues. Finally, the California Supreme
Court's preemption ruling has the potential to significantly alter the
role of private citizens in food law-a drastic evolution from the ca-
veat emptor origin of this body of law.
More Palatable Solution? Comparing the Viability of Smart Growth Statutes to Other Legis-
lative Methods of Controlling the Obesity Epidemic, 2007 Wis. L. REv. 1091 (2007).
244. Pelman v. McDonald's Corp., 452 F. Supp. 2d 320, 328 (S.D.N.Y 2006) (deny-
ing defendant's motion to dismiss).
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APPENDIX A
245. Press Release, Wal-Mart Stores, Inc., Wal-Mart Offers Private Label Milk
Produced without Artificial Growth Hormone (Mar. 21, 2008) available at
http://walmartstores.com/PrintContent.aspx?id=8147.
246. Press Release, Kroger Co., Kroger to Complete Transition to Certified rBST-
Free Milk by Early 2008 (Aug. 1, 2007) available at
http://www.thekrogerco.com/corpnews/corpnewsinfo-pressreleases_08012007.ht
m.
247. Coles, supra note 54.
CORPORATE POLICIES REGARDING RBST USE
AND LABELING OF DAIRY PRODUCTS
Company rBST Policy
Wal-Mart "Suppliers of the company's
Great Value milk have pledged to
source exclusively from cows that
have not been treated with artifi-
cial growth hormones . . . Sam's
Club is also exclusively offering
milk selections from suppliers




Kroger "Kroger transitioned the milk
it sells in the western half of the
U.S. to a certified rBST-free sup-
ply .... Milk the Company proc-
esses and sells in its stores
throughout the Midwest and
Southeast will also be certified as
rBST-free.
246
Starbucks Entire milk supply for all
American locations are free of
synthetic bovine growth hor-
mones (rBST) at of then end of
2007.247
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248. Natural Cheese with no rBST, KRAFT FOODS, INC., (last visited Dec. 1, 2008)
http://www.kraftfoods.com/kf/Products/WhatsNewLatestAndFavorites.htm.
249. Rachel Melcer, Lawmakers Consider Bill to Restrict Labels on Milk Containers,
ST. Louis POST-DISPATCH, Apr. 17, 2008, available at http://www.stltoday.
com/stltoday/business/stories.nsf/0/13086DAB9EFE22AA8625742E000CODD7?O
penDocument.
250. Schuck Markets, Inc. is headquartered in St. Louis, MO, along with Mon-
santo, the developers of rBST. About Schnuck Markets, Schuncks, http://www.
schnucks.com/about.asp#history (last visited Sept. 22, 2008).
251. Rachel Melcer, Lawmakers Consider Bill to Restrict Labels on Milk Containers,
ST. Louis POST-DISPATCH, April 17, 2008.
252. Press Release, Meijer, Meijer Offers Milk Produced without Artificial Growth
Hormone (Feb. 19, 2008) available at http://img.meijer.com/assets/cms/pdfs/
news/20080219_meijerMilkRelease.pdf.
Kraft Produces a line of 2% Milk
Natural Cheese made without
added growth hormones. Kraft
includes the FDA's recom-
mended disclaimer on their
products and on their website.2
Shop 'n Save "Nearly all" of the company's
milk comes from rBST-free dair-
ies 249
Schnuck Markets250  "Schnuck Markets sells only
rBST-free milk locally, but it does
not advertise or promote that
fact.
,,251
Meijer Retailer offers its own-brand
milk exclusively from cows that
have not been treated with artifi-
cial growth hormones, including
rBST. 2 52
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255. George Raine, Got rbST in your milk? Dairy co-op bows to pressure to stop use of
hormone, SAN FRANCISCO CHRONICLE, Mar. 25, 2007, available at
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2007/03/25/BUGBROQASE1.
DTL.
256. Jane Akre, A Decade of Consumer Pressure Is Driving Monsanto's Bovine Growth
Hormone off the Market, ORGANIC CONSUMERS ASSOCIATION, available at
http://www.organicconsumers.org/articles/article_14008.cfm.
257. WHOLE FOODS MARKETS, Cheese, http://www.wholefoodsmarket.com/
products/cheese.php.
258. TRADER JOE'S, What We Sell, http://www.traderjoes.com/product-
categories.html.
Publix Publix's "private label brand
milk, including whole, reduced
fat, low fat, fat free, chocolate
and low-fat chocolate, in all sizes,
will be rbST (recombinant bovine
somatotropin) free. ''2' 5
The company includes the
FDA's recommended disclaimer
on its website .254
Safeway Safeway no longer accepts milk
from cows treated with rBST .2
Chipotle Mexican Grill Chipotle no longer uses dairy
products from cows treated with
rBST.2'6
Whole Foods Market "Because we always have your
best interests in mind, many of
the cheeses we sell are organic
and most of them are free of
rBST (recombinant bovine
growth hormone, that is). And we
don't sell any cheese that con-
tains artificial flavors, colors or
preservatives either.
257
Trader Joe's Trader Joe's has banned the
use of rBST in production of
their milk and butter products.' 8
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